Skip to main content
. 2020 Dec 1;26(4):10.7196/AJTCCM.2020.v26i4.110. doi: 10.7196/AJTCCM.2020.v26i4.110

Table 2. Clinical investigations.

Findings on ECG Median (IQR) n (%)
P 0
Right-axis deviation 1 (5)
S wave in standard lead 1 3 (15)
Q wave in standard lead 3 2 (10)
T wave in standard lead 3 1 (5)
R wave in ventricular lead 1 1 (5)
RVH 0
RV strain 1 (5)
RBBB 0
Findings on chest X-ray
  Elevated cardiac apex 10 (50)
  Enlarged right atrium 10 (50)
  Enlarged pulmonary arteries 15 (75)
  Pruning of peripheral pulmonary vessels 5 (25)
  Pleuro-parenchymal bands 12 (60)
  Volume loss 2 (10)
  Tracheal deviation 0
Spirometry
  FEV1 2.77 (2.29 - 3.31)
  FVC 3.41 (2.82 - 3.96)
  Ratio 82.85 (73.10 - 86.85)
  DLCO (%Pred) 99.5 (84.5 - 108.5)
  Low DLCO 3 (15)
  Room air saturation 96 (95.5 - 97.0)
Echocardiography
  LVIDd (mm) 43.5 (41.5 - 48.5)
  LVIDs (mm) 28 (27.5 - 30)
  LVEF (%) 60 (56 - 64)
  RWMA 0
  Left atrium (mm) 27.5 (23 - 31)
  Ascending aorta (mm) 23 (21 - 26.5)
  E/a 1.24 (1 - 1.50)
  E/e 6 (5.19 - 8.30)
  Diastolic dysfunction 3 (15)
  Aortic regurgitation 1 (5)
  Aortic stenosis 0
  Mitral regurgitation 2 (10)
  Mitral stenosis 0
  Tricuspid regurgitation 5 (25)
  TAPSE (mm) 21 (19 - 23)
  TAPSE <16 mm 0
  PASP (mmHg) 18 (8.5 - 24.5)
  RAP (mmHg) 5 (3 - 9.5)
  IVC (mm) 14 (13 - 18)
  NT-proBNP 26 (16 - 66)

ECG = electrocardiography

IQR = interquartile range

P = pulmonale

R = right-axis deviation

RVH = right ventricular hypertrophy

RV = right ventricular

RBBB = right bundle branch block

FEV1 = forced expiratory volume in one second

FVC = forced vital capacity

DLCO = diffusing capacity of lung for carbon monoxide

LVIDd = left ventricular internal diameter end diastole

LVIDs = left ventricular internal diameter end systole

LVEF = left ventricular ejection fraction

RWMA = regional wall motion abnormality

TAPSE = tricuspid annular plane systolic excursion

PASP = pulmonary hypertension echocardiography

RAP = right arterial pressure

IVC = inferior vena cava

NT-proBNP = N-terminal pro-B-type natriuretic peptide